Holen Sie sich die Stockscreener-App
1.09
1.87%
0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LXRX?
Forum
Prognose
Aktiensplit
Finanzdaten der Lexicon Pharmaceuticals Inc-Aktie (LXRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2,187%
28.87
|
1.262 | 26.55 | 1.75 | 1.647 |
| Cost Of Revenue |
10.00%
0.033
|
0.03 | 0.348 | 0.071 | 0.166 |
| Gross Profit |
2,240%
28.83
|
1.232 | 26.21 | 1.679 | 1.481 |
Operating Expenses
|
6.74%
25.10
|
26.91 | 58.94 | 65.37 | 56.84 |
| Benefits Costs and Expenses |
6.72%
25.13
|
26.94 | 59.29 | 65.44 | 57.00 |
| Costs And Expenses |
6.72%
25.13
|
26.94 | 59.29 | 65.44 | 57.00 |
| Operating Income/Loss |
114.55%
3.736
|
-25.68 | -32.74 | -63.69 | -55.35 |
| Income/Loss From Continuing Operations Before Tax |
114.77%
3.736
|
-25.30 | -32.74 | -63.69 | -53.43 |
| Income/Loss From Continuing Operations After Tax |
112.86%
3.252
|
-25.30 | -33.77 | -64.81 | -53.43 |
|
Net Income/Loss
|
112.86%
3.252
|
-25.30 | -33.77 | -64.81 | -53.43 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.34%
363.29
|
362.07 | 13.92 | 361.49 | 310.84 |
| Diluted Average Shares |
0.41%
363.57
|
362.07 | 13.92 | 361.49 | 310.84 |
| Basic Earnings Per Share |
114.29%
0.01
|
-0.07 | -0.09 | -0.18 | -0.17 |
| Diluted Earnings Per Share |
114.29%
0.01
|
-0.07 | -0.09 | -0.18 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):